Dow Up0.25% Nasdaq Up0.65%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
3.38 Up 0.02(0.60%) 4:00PM EDT
|After Hours : 3.34 Down 0.04 (1.18%) 4:00PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
Total Revenue 4,820   4,602   10,987   25,842  
Cost of Revenue -  7  1,346   -  
Gross Profit 4,820   4,595   9,641   25,842  
Operating Expenses
Research Development20,579  19,047  20,067  16,524  
Selling General and Administrative3,212  2,721  2,731  3,534  
Non Recurring77  21  5  442  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (19,048) (17,194) (13,162) 5,342  
Income from Continuing Operations
Total Other Income/Expenses Net(2,314)397  (218)865  
Earnings Before Interest And Taxes(21,362)(16,797)(13,380)6,207  
Interest Expense1,470  1,338  1,241  1,306  
Income Before Tax(22,832)(18,135)(14,621)4,901  
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(22,832)(18,135)(14,621)4,901  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (22,832) (18,135) (14,621) 4,901  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (22,832) (18,135) (14,621) 4,901  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.